Nebula Research & Development LLC Phibro Animal Health Corp Call Options Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PAHC
# of Institutions
148Shares Held
20.4MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.5MShares$75.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.49MShares$32.3 Million0.0% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA1.48MShares$32.1 Million0.4% of portfolio
-
Richard Pzena Pzena Investment Management LLC1.46MShares$31.6 Million0.11% of portfolio
-
State Street Corp Boston, MA905KShares$19.6 Million0.0% of portfolio
About PHIBRO ANIMAL HEALTH CORP
- Ticker PAHC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 20,337,600
- Market Cap $440M
- Description
- Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...